HLA-DQ2 is a genetic risk marker for celiac disease, an autoimmune condition triggered by gluten. In untreated celiac disease, inflammatory damage to the small intestinal lining can cause malabsorption, which may lead to blood sugar fluctuations – especially after carbohydrate-rich meals. Additionally, individuals with celiac disease have an increased risk of type 1 diabetes, another autoimmune disease. However, a positive HLA-DQ2 result alone does not indicate active celiac disease or blood sugar problems; most carriers never develop celiac disease. There is no established direct causal effect of HLA-DQ2 on fasting glucose or insulin sensitivity. Practical advice: If celiac disease is suspected (e.g., diarrhea, fatigue, unexplained blood sugar swings), serological testing (tTG-IgA) and possibly duodenal biopsy should be performed. Blood glucose should be measured clinically – a DNA test does not replace standard lab diagnostics. Caveat: Do not self-treat; consult a physician if symptoms arise.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-776217cd9ce71722178877e3